SB 688 (2020)
Add drug pricing to the Consumer Protection Act
This bill became law.
Last updated 2024-02-27 4:18 pm
Summary:
Requires the Department of Health and Human Services to notify the Department of Justice of large price increases for essential off-patent or generic drugs. The bill authorizes the Department of Justice to investigate when notified of suspected price gouging. The Senate amended the bill to instead make clear that unfair pricing of generic prescription drugs falls under the Consumer Protection Act. The Senate added this bill to HB 1280.
Status Detail:
Added to a Different Bill
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills.
Browse related articles and bills:
